Skip to main content
Premium Trial:

Request an Annual Quote

Myriad Genetics Nears Spin-off Date for Pharma Business

NEW YORK (GenomeWeb News) – Myriad Genetics announced after the close of the market on Thursday that its board of directors has set the record and distribution dates for the spinoff of its wholly owned subsidiary, Myriad Pharmaceuticals.

The firm said that Myriad Genetics' shareholders of record on June 17 will receive on June 30 a pro-rata dividend of .25 share of Myriad Pharmaceuticals common stock for each share of Myriad Genetics held. Fractional shares will be paid in cash.

Myriad had announced its plans to split up the businesses last October, with plans for Myriad Genetics to retain the molecular diagnostics business, and Myriad Pharmaceuticals to focus on drug development programs.

Myriad said today that in an effort to help facilitate research programs at Myriad Pharmaceuticals it would transfer $188 million to the spinoff.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.